This difference persisted after adjusting for confounding factors such as age, sex, and apolipoprotein (Apo) E 4 genotype [47, 48]
Medication Adjustments : Increasing the GLP-1 dose (if tolerated) or adding another medication that targets a different pathway may be effective for some
A., Wharton, S., Yokote, K., Kushner, R
Sarrafzadegan N, Mohammadifard N (2019) Cardiovascular disease in Iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention
Research indicates protection against hypoxia-induced damage, making it relevant for cardiac arrest and respiratory failure research